In this episode, David interviews Grof-certified Holotropic Breathwork® practitioner, author, developer of InnerEthics®, and Vital instructor: Kylea Taylor: M.S., LMFT; and therapist and Vital student: Shabina Hale.
In this episode, Joe interviews Gina Gratza, MS, LMFT: Portland, OR-based research therapist and educator at InnerTrek, a psilocybin facilitator training program. She discusses MDMA, Burning Man, therapy, psilocybin, and more.
In this episode, David interviews clinical psychologist and Vital instructor, Dr. Dominique Morisano, and facilitator and Vital student, Jessika Lagarde, about their perspectives on psychedelic education, and of course, Vital.
www.psychedelicstoday.com
In this episode, David interviews Raad Seraj: host of Minority Trip Report, a podcast for underrepresented views in psychedelics/mental health, and founder of Mission Club, an education & investment platform.
www.psychedelicstoday.com
In this episode, Joe is joined by Kyle, calling in from a retreat in Jamaica. They discuss data Concerns in Oregon, hopeful legalization in NH and Missouri, and Vital: the retreats, what students are saying, and the 5 elements.
www.psychedelicstoday.com
In this episode, Kyle interviews researcher, writer, and one of the world’s leading experts on 5-MeO-DMT, Dr. Malin Vedøy Uthaug. She discusses Heron’s theory of catharsis, dietas, freediving, the mind-body connection, and more.
www.psychedelicstoday.com
In this episode, Joe covers Prince Harry coming out of the psychedelic closet, Virginia lawmakers proposing the legalization of psilocybin, psychedelic legislation already in plans for nearly a dozen states in 2023, and more.
www.psychedelicstoday.com
In this episode, Joe interviews neurobiologist, researcher, & author, Dr. Andrew R. Gallimore, who discusses his newest book: "Reality Switch Technologies", DMT, intravenous infusion pumps, John Mack, Terence McKenna, and more!
www.psychedelicstoday.com
In this episode, David and Joe discuss Tryp Therapeutics researching psilocybin-assisted psychotherapy for I.B.S.; NY lawmakers pre-filing a bill to legalize natural psychedelics; and British Columbia decriminalizing drugs.
www.psychedelicstoday.com
In this episode, Kyle interviews author and board-certified psychiatric-mental health nurse practitioner, C.J. Spotswood. They discuss microdosing and why nurses could be the answer to the psychedelics and scalability problem.
www.psychedelicstoday.com
In this episode, Joe and Kyle cover a study where psilocybin improved stress response; The Economist highlighting psychedelic medicine as a main story for 2023; and the Minnesota Medical Association endorsing decriminalization.
www.psychedelicstoday.com
In this episode, David interviews internationally recognized Indigenous rights activist: Sutton King, MPH. She discusses the challenges Indigenous people continue to face from intergenerational trauma, and their resiliency.
www.psychedelicstoday.com
In this episode, Joe and Kyle discuss concerns over Prop 122 and data privacy, the hopeful end to the sentencing disparity between crack cocaine and powder; and the cost vs. value problem of psychedelic therapy: is it worth it?
www.psychedelicstoday.com
In this episode, Joe interviews Zach Leary: author, facilitator, trainer, host of the MAPS podcast, and of course, son of psychedelic legend: Timothy Leary. They discuss Ram Dass, Michael Pollan, flotation tanks, and more.
www.psychedelicstoday.com
In this episode, Joe & David discuss the DA dropping a felony drug charge against a Denver mushroom rabbi, the economics of psychedelic-assisted therapies, and the belief that most US states will legalize psychedelics by 2037.
In this episode, Joe interviews New York Times best-selling author, pioneer in the field of integrative medicine, legend in the health and wellness space, and (somewhat surprising to us) psychedelic advocate, Andrew Weil, M.D.
www.psychedelicstoday.com
In this episode of Psychedelics Weekly, Joe and David discuss methylation and genetic memory; why the term, “The Psychedelic Renaissance” is problematic; and the importance of harm reduction – especially at music festivals.
www.psychedelicstoday.com
In this episode, David interviews Sherry Rais: CEO/Co-Founder of Enthea, a benefit plan administrator offering psychedelic-assisted therapy as a benefit to interested employers.
www.psychedelicstoday.com
In this episode, Joe and Alexa discuss our first conference-meets-festival, Convergence; a study looking at the potentiality of 5-MeO-DMT reactivation; and the story of a woman using cannabis as an adjunct treatment for cancer.
www.psychedelicstoday.com
In this episode, Victoria interviews James Fadiman, Ph.D., Adam Bramlage, and Conor Murray, Ph.D, who discuss the benefits of microdosing and the first-ever take-home wireless EEG microdosing study (which you can be a part of).
www.psychedelicstoday.com
In this episode, David, Joe, (and in her first appearance) Alexa Jesse discuss The PACT Caucus and Breakthrough Therapies Act, Jim Harris overcoming paralyzation through psilocybin, and research on chronic pain and Alzheimer's.
In this episode, Kyle interviews Marc Aixalà, writer of "Psychedelic Integration: Psychotherapy for Non-Ordinary States of Consciousness." They discuss what integration truly is, and how it should be more personalized.
www.psychedelicstoday.com
In this episode of Psychedelics Weekly, David welcomes Jon Dennis, Esq. They discuss Colorado Prop 122 and Jon gives an update on Oregon's legal psilocybin as the Oregon Health Authority finalizes its proposed rules.
www.psychedelicstoday.com
In this episode, David interviews Co-Medical Director of Nue Life, Dr. Ben Medrano. He discusses the risks, safety, and efficacy of at-home ketamine, Nue Life's recent study in Frontiers, and Nue Life's Nue Care program.
www.psychedelicstoday.com
In this inaugural episode of Psychedelics Weekly, Joe and Kyle are back together again to kick off a new weekly show. In this episode, they discuss the recent Wonderland controversy and Colorado Proposition 122.
www.psychedelicstoday.com